by Chris Harper — Tuesday, October 14, 2025, 04:51 PM EDT It has been a tumultuous time for Destiny 2—and even as we were writing this with the game showing its lowest player count ever, Bungie ...

Since its launch in 2017, Bungie has released many Destiny 2 expansions. They vary in size, price, and quality, but all introduce new content for you to get stuck into. However, with several years of ...

Bungie has partnered with Green Man Gaming Bundles to give Destiny 2 players a chance to get their hands on all the game's DLC on the cheap via the Destiny 2 2025 Charity Bundle. Though its contents ...

Derek's love of games came at an early age when his parents first brought home the Nintendo Entertainment System. From then on, countless nights were spent hunting ducks, stomping turtles, exploring ...

Say what you will about Bungie, but it does like to try and shake up big parts of the core Destiny 2 experience from time to time. And, after slowly diminishing the number of bounty-carrying vendors, ...

Garima Kapoor is the Co-founder & Co-CEO of MinIO, the only pure-play exascale object store for secure, enterprise AI data. In today’s enterprise landscape, data is no longer a byproduct of business, ...

Destiny 2’s recent Edge of Fate expansion marked the game’s seventh mainline annual expansion, and if there’s one thing that’s never been clearer, it’s that Bungie’s MMO/loot-shooter is tough for new ...

The 9.1.5.1 Patch for Destiny 2 has arrived, bringing with it a number general updates, balance adjustments, and various bug fixes. This page acts as a comprehensive breakdown of the 9.1.5.1 Patch for ...

The makers of BIND, the Internet’s most widely used software for resolving domain names, are warning of two vulnerabilities that allow attackers to poison entire caches of results and send users to ...

U.S. medical imaging provider SimonMed Imaging is notifying more than 1.2 million individuals of a data breach that exposed their sensitive information. SimonMed Imaging is an outpatient medical ...

Danish vaccine developer Evaxion has released long-term data for its lead personalized cancer vaccine, with the shot scoring a 75% objective response rate (ORR) in patients with advanced melanoma ...